Literature DB >> 2690818

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

B P Morgan1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2690818      PMCID： PMC1133540          DOI： 10.1042/bj2640001

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  131 in total

1.  Non-lethal complement-membrane attack on human neutrophils: transient cell swelling and metabolic depletion.

Authors:  B P Morgan
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.

Authors:  D F Carney; C H Hammer; M L Shin
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 3.  G protein involvement in receptor-effector coupling.

Authors:  P J Casey; A G Gilman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

Review 4.  Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.

Authors:  S H Ohanian; S I Schlager
Journal:  Crit Rev Immunol       Date:  1981-01       Impact factor: 2.214

Review 5.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

6.  Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components.

Authors:  G M Hänsch; M Seitz; G Martinotti; M Betz; E W Rauterberg; D Gemsa
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

7.  Size distribution and stability of the trans-membrane channels formed by complement complex C5b-9.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  Mol Immunol       Date:  1983-02       Impact factor: 4.407

8.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.

Authors:  S Schönermark; E W Rauterberg; M L Shin; S Löke; D Roelcke; G M Hänsch
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

9.  Prelytic reduction of high-energy phosphates induced by antibody and complement in nucleated cells. 31P-NMR study.

Authors:  R Tirosh; H Degani; G Berke
Journal:  Complement       Date:  1984

10.  Effect of fatty acid modifications of cultured hepatoma cells on susceptibility to complement-mediated cytolysis.

Authors:  T J Yoo; H C Chiu; A A Spector; R S Whiteaker; G M Denning; N F Lee
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701
View more
  103 in total

1.  Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.

Authors:  S Kraus; R Seger; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Modulation of complement membrane attack by local C7 synthesis.

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 3.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

4.  Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.

Authors:  B J Czermak; A B Lentsch; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

5.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 6.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

7.  Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

8.  Blebbing confers resistance against cell lysis.

Authors:  E B Babiychuk; K Monastyrskaya; S Potez; A Draeger
Journal:  Cell Death Differ       Date:  2010-07-02       Impact factor: 15.828

9.  Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.

Authors:  Saifur R Ahmad; Elaine A Lidington; Rieko Ohta; Noriko Okada; Michael G Robson; Kevin A Davies; Michael Leitges; Claire L Harris; Dorian O Haskard; Justin C Mason
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Regulation of complement membrane attack complex formation in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.